---
figid: PMC8571135__292_2021_946_Fig1_HTML
figtitle: BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free
  therapeutic options
organisms:
- NA
pmcid: PMC8571135
filename: 292_2021_946_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8571135/figure/Fig1/
number: F1
caption: 'The MAPK signaling pathway (figure modified from Taieb et al. [] CC BY licence).
  a MAPK pathway: signal enhancement in the presence of an activating BRAF mutation.
  b Inhibition of BRAF activated by mutation leading to suppression of the ERK-mediated
  negative feedback loop and reactivation of the MAPK signaling pathway via CRAF.
  c Counteracting resistance mechanisms: mechanism of action of combined BRAF and
  EGFR blockade. BRAF rapidly accelerated fibrosarcoma isoform B; CRAF rapidly accelerated
  fibrosarcoma isoform C; EGFR epidermal growth factor receptor; ERK extracellular
  signal-regulated kinase; MAPK mitogen-activated protein kinase; MEK MAPK/ERK kinase;
  RAS rat sarcoma protooncogene'
papertitle: BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free
  therapeutic options.
reftext: Michael Hummel, et al. Pathologe. 2021;42(Suppl 1):98-109.
year: '2021'
doi: 10.1007/s00292-021-00946-5
journal_title: Der Pathologe
journal_nlm_ta: Pathologe
publisher_name: Springer Medizin
keywords: Cetuximab | Encorafenib | BRAF-inhibitors | Protein kinase inhibitors |
  Proto-oncogene proteins B‑raf | BRAF-Inhibitoren | Proteinkinaseinhibitoren | Protoonkogene
  B‑Raf-Proteine
automl_pathway: 0.9440126
figid_alias: PMC8571135__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC8571135__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8571135__292_2021_946_Fig1_HTML.html
  '@type': Dataset
  description: 'The MAPK signaling pathway (figure modified from Taieb et al. [] CC
    BY licence). a MAPK pathway: signal enhancement in the presence of an activating
    BRAF mutation. b Inhibition of BRAF activated by mutation leading to suppression
    of the ERK-mediated negative feedback loop and reactivation of the MAPK signaling
    pathway via CRAF. c Counteracting resistance mechanisms: mechanism of action of
    combined BRAF and EGFR blockade. BRAF rapidly accelerated fibrosarcoma isoform B;
    CRAF rapidly accelerated fibrosarcoma isoform C; EGFR epidermal growth factor
    receptor; ERK extracellular signal-regulated kinase; MAPK mitogen-activated protein
    kinase; MEK MAPK/ERK kinase; RAS rat sarcoma protooncogene'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - rl
  - oo
  - Egfr
---
